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Abstract
It is increasingly of interest in statistical genetics to test for the presence of a mech-
anistic interaction between genetic (G) and environmental (E) risk factors by testing
for the presence of an additive G×E interaction. In case-control studies involving a
rare disease, a statistical test of no additive interaction typically entails a test of no
relative excess risk due to interaction (RERI). It is also well known that a test of mul-
tiplicative interaction exploiting G-E independence can be dramatically more powerful
than standard logistic regression for case-control data. Likewise, it has recently been
shown that a likelihood ratio test of a null RERI incorporating the G-E independence
assumption (RERI-LRT) outperforms the standard RERI approach. In this paper, the
authors describe a general, yet relatively straightforward approach to test for G×E ad-
ditive interaction exploiting G-E independence. The approach which relies on regression
models for G and E is particularly attractive because, unlike the RERI-LRT, it allows
the regression model for the binary outcome to remain unrestricted. Therefore, the new
methodology is completely robust to possible mis-specification in the outcome regres-
sion. This is particularly important for settings not easily handled by RERI-LRT, such
as when E is a count or a continuous exposure with multiple components, or when there
are several auxiliary covariates in the regression model. While the proposed approach
avoids fitting an outcome regression, it nonetheless still allows for straightforward co-
variate adjustment. The methods are illustrated through an extensive simulation study
and an ovarian cancer empirical application.
Keywords: gene-environment additive interaction, gene-environment independence, case-
control study
1
ar
X
iv
:1
80
8.
06
03
8v
1 
 [s
tat
.M
E]
  1
8 A
ug
 20
18
1 Introduction
There is growing interest in the development and application of statistical methods to detect
the presence of an additive gene (G)-environment (E) interaction because such interaction may
be closer to a true mechanistic interaction than its multiplicative counterpart [1, 2, 3, 4, 5].
For case-control data involving a rare disease, a statistical test of no additive G×E interaction
is easily performed via a test of a null relative excess risk due to interaction (RERI) [6]. This
approach has gained popularity in epidemiology primarily because it is easily performed using
relative risk estimates from a standard logistic regression for case-control data [6]. When G
and E are known to be independent in the target population, it is well known that a test
of multiplicative interaction incorporating the independence assumption can be dramatically
more powerful than standard logistic regression, which does not make use of the assumption [7,
8, 9, 10, 11]. Likewise, it was recently shown that a likelihood ratio test of the null hypothesis
of no RERI incorporating the G-E independence assumption (hereafter RERI-LRT) generally
outperforms the standard RERI test of no additive interaction [12]. Notably, RERI-based
tests of additive interaction rely on correct specification of a logistic model for the binary
outcome, as a function of G, E and auxiliary covariates. Ideally, a nonparametric specification
of the outcome logistic regression would in principle ensure validity of RERI-based tests.
However, nonparametric estimation may not be feasible if, as often the case in practice, the
environmental exposure or auxiliary covariates in the model include multiple factors, including
count or continuous variables. Thus, in practice it is customary to specify a parametric
logistic outcome model, therefore producing a parametric test of the null hypothesis of no
RERI. Unfortunately, as we argue in Section 3.1, parametric RERI test statistics based on a
standard specification of a logistic outcome regression, will a priori rule out the null hypothesis
of no additive interaction in most practical situations where at least one exposure is either
a count or continuous, therefore leading to inflation of its type 1 error rate. The presence
of covariates has previously been noted as also potentially problematic for RERI by [13].
He has argued, quite convincingly that given a conceptualization of interaction as departure
from additive risks, making direct inferences regarding the fundamental additive interaction
parameter would be preferred to the common indirect strategy based on RERI, in order to
avoid potential bias due to model misspecification of the outcome regression. We therefore re-
iterate Skrondal’s warning against the indiscriminate use of parametric RERI-based tests of
interaction in settings where saturated or nonparametric specification of the outcome model
is not practical.
In this paper, the authors present a general, yet fairly straightforward approach to directly
test for the presence of additive G×E interaction in case-control studies without requiring
a regression model of disease risk. The proposed approach which is easily made to exploit
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the G-E independence assumption leading to dramatic increase in power, relies on separate
regression models for G and E given covariates. By avoiding specification of an outcome
model, the approach circumvents aforementioned difficulties with RERI-based tests and is
completely robust to mis-specification of the outcome regression. However, as noted above,
correct specification of models for G and E is instead needed for the new approach to be
valid. Nonetheless, unlike RERI-based tests, standard parametric models can be used for the
latter in most practical situations, even if E is continuous without a priori ruling out the
null hypothesis of no additive interaction. The methods are illustrated through an extensive
simulation study in the simple setting of binary G and E with no additional covariates so
that RERI and the new approach equally apply and can be directly compared in terms of
power. Additional simulations are performed to illustrate the poor behavior of parametric
RERI-based tests in more practical scenarios. Next, we demonstrate the new approach using
data from an ovarian cancer study to detect an additive interaction between the BRCA1/2
genetic variant (G), and the woman’s parity and number of years of oral contraceptive use
(E). Because both environmental exposures are counts, the RERI-LRT cannot easily be im-
plemented without possibly recoding the original environmental exposures as dichotomous
or as categorical with few levels. Covariate adjustment needed in the study also presents
additional difficulty for RERI-LRT and for these reasons the approach is forgone in both
applications in favor of the new methodology.
2 Alternative characterization of test of additive inter-
action
Suppose one has observed case-control data on n unrelated individuals, let D denote the rare
disease outcome defining case-control status and (A1, A2) denote two exposures in view. For
instance, in a statistical genetic application, A1 may denote the genetic variant G and A2 an
environmental exposure E, however, we will use the more generic notation (A1, A2) to allow
for more general contexts considered in Section 4, say where either or both exposures may be
count or continuous. Let µ(a1, a2) = Pr(D = 1|A1 = a1, A2 = a2) denote the disease risk of
individuals in the target population with exposure values (a1, a2).
2.1 Binary exposures
In the case of binary genetic variant and environmental exposure, we have the following
saturated model
µ(A1, A2) = β0 + β1A1 + β2A2 + β3A1A2.
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Therefore, an additive interaction between A1 and A2 is said to be present if
β3 = µ(1, 1)− µ(1, 0)− µ(0, 1) + µ(0, 0) 6= 0,
or equivalently if RERI 6= 0, where
RERI = {µ(1, 1)− µ(1, 0)− µ(0, 1)} /µ(0, 0) + 1
= β3/µ(0, 0).
An empirical version of RERI is obtained under case-control sampling by estimating the
required risk ratios µ(a1, a2)/µ(0, 0), via a saturated logistic regression under the rare disease
assumption. Then, standardizing the empirical estimate R̂ERI by a consistent estimate of
its standard error
√
σ̂2RERI gives the RERI test statistic TRERI = R̂ERI/
√
σ̂2RERI . It can
then be showed using standard asymptotic arguments that under the null hypothesis we wish
to test, of no additive interaction H0 : β3 = RERI = 0, TRERI is approximately standard
normal in large samples.
The following result gives an alternative characterization of the null hypothesis of no
additive interaction which motivates the new approach. To state the result, let pi1 (a2) =
Pr(A1 = 1|A2 = a2) denote the prevalence of the first exposure A1 among individuals with
the second exposure A2 = a2 in the underlying population, and likewise define pi2(a1) =
Pr(A2 = 1|A1 = a1). Also let α denote the log odds ratio association relating A1 and A2 in
the target population, thus
expα =
pi1 (1) (1− pi1 (0))
pi1 (0) (1− pi1 (1))
such that α = 0 encodes the independence assumption between A1 and A2.
Result 1. We have that the null hypothesis of no additive interaction H0 holds if and only
if
RERI = 0⇔ E {U |D = 1} = 0
where
U = e−αA1A2 (A1 − pi1(0)) (A2 − pi2(0))D.
We should note that Result 1 does not rely on the rare disease assumption and holds
irrespective of the population disease prevalence. The result is a special case of a more general
lemma given later in the text allowing for arbitrary exposures and for covariate adjustment.
According to the result, the null hypothesis of no additive interaction holds if and only if
RERI is equal to zero, or equivalently if and only if the random variable U has mean zero
among cases (D = 1). Intuition about the result is gained by assuming G-E independence,
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i.e. α = 0, such that pij(a) = pij. Then, upon noting that the conditional density of (A1, A2)
given D = 1 is proportional to
µ(A1, A2)f1(A1)f2(A2) = (β0 + β1A1 + β2A2 + β3A1A2)f1(A1)f2(A2)
where fj(1) = pij, one observes that E {U |D = 1} is proportional to∑
a1,a2
(a1 − pi1) (a2 − pi2) (β0 + β1a1 + β2a2 + β3a1a2)f1(a1)f2(a2)
= β0
∑
a1,a2
(a1 − pi1) (a2 − pi2) f1(a1)f2(a2)︸ ︷︷ ︸
=0
+ β1
∑
a1,a2
(a1 − pi1) (a2 − pi2) a1f1(a1)f2(a2)︸ ︷︷ ︸
=0
+ β2
∑
a1,a2
(a1 − pi1) (a2 − pi2) a2f1(a1)f2(a2)︸ ︷︷ ︸
=0
+ β3
∑
a1,a2
(a1 − pi1) (a2 − pi2) a1a2f1(a1)f2(a2)
= β3pi1 (1− pi1) pi2 (1− pi2) ,
confirming that E {U |D = 1} = 0 if and only if the additive interaction β3 = 0. Result 1
further shows that a similar result holds when the exposures are dependent upon applying a
weight to individuals with both exposures, equal to the inverse of the odds ratio association of
the two exposures. Intuitively, weighting makes the exposures independent, thus essentially
recovering the independent exposure setting in the weighted sample. Since U only uses
exposure data among cases (with D = 1), the result suggests that one may be able to test
for additive interaction by considering whether the distribution of the exposures in view
satisfies the above condition using data for cases only. Unfortunately, U is not directly
observed and therefore cannot directly be used for inference, as it depends on the unknown
population parameters pij(0), j = 1, 2. Nonetheless, progress can be made under the rare
disease assumption, since one may use the controls (with D = 0) for approximate inference,
upon observing that pij(0) ≈ pj(0) where p1(a2) = Pr(A1 = 1|A2 = a2, D = 0) and p2(a1) =
Pr(A2 = 1|A1 = a1, D = 0). Specifically, let ω = log[p1(1)(1 − p1(0))/p1(0)(1 − p1(1))], then
ω ≈ α under the rare disease assumption. Therefore, one may estimate ∑i Ui with ∑i Ûi
where
Ûi = exp (−A1,iA2,iω̂) (A1,i − p̂1(0)) (A2,i − p̂2(0))Di,
with p̂1(a) =
∑
iA1,iI(A2,i = a,D = 0)/
∑
i I(A2,i = a,D = 0) the sample version of p1(a),
p̂2(a) similarly defined, and exp(ω̂) = p̂1(1)(1 − p̂1(0))/p̂1(0)(1 − p̂1(1)) the sample odds
ratio relating A1 and A2 in the controls. In the Appendix, we show how to derive σ
2
Û
=
5
V ar(
∑
i Ûi/n) (see equation (1) of the Appendix). Suppose that unbeknownst to the analyst,
A1 and A2 are independent in the population and therefore ω̂ converges to 0 in probability.
We evaluate σ2
Û
at this particular submodel and show that σ2
Û
can be decomposed as σ̂2
Û
=
V̂1+ V̂2+ V̂3, where V̂j is an estimate of Vj, j = 1, 2, 3, described in the Appendix. Considering
in turn each contribution to the variance, we note that the first term V̂1 captures the variance
of
∑
i Ui/n if (ω, p1(0), p2(0)) were known; the second term V̂2 reflects the uncertainty due
to estimation of (p1(0), p2(0)); while V̂3 reflects the uncertainty associated with estimation
of the odds ratio parameter ω. In the next section, we further consider how the explicitly
leveraging G-E independence assumption alters each of these contributions to reveal how the
assumption can improve power to detect the presence of an additive interaction.
Here we note that, under H0 the standardized test statistic T =
∑
i Ûi/
(
n
√
σ̂2
Û
)
is
approximately standard normal in large samples. Under the two-sided alternative hypothesis
β3 6= 0, one can further show that in large samples, T has approximate variance one, and is
approximately centered at the non-centrality parameter κ× β3, where:
κ = p1(0) (1− p1(0)) p2(0) (1− p2(0))λ/σ2Û ,
λ is the sampling fraction of cases (i.e. λ = proportion of cases in case-control sample/proportion
of cases in population). Thus, T has asymptotic power one since 1/σ2
Û
and therefore κ tends
to infinity with sample size; confirming that similar to TRERI , T is a consistent test statistic
of H0.
Interestingly, the above derivation also implies that the statistic
∑
i Ûi/{p̂1 (1− p̂1(0)) p̂2(0)(1−
p̂2(0))
∑
iDi} gives a consistent estimate of β3/Pr{D = 1} the interaction parameter of in-
terest scaled by the inverse of the population disease prevalence. Thus, one could in principle
recover a consistent estimate of β3 if either the underlying population disease prevalence or
the sampling fraction of cases were known.
We note that neither T nor TRERI makes explicit use of the G-E independence assumption
and therefore both may be inefficient when the assumption holds. In the following section, we
modify T to explicitly encode the independence assumption thus obtaining a more powerful
test statistic.
2.2 Test incorporating independence assumption
Suppose that A1 and A2 are known to be independent in the population. Naturally, one
may wish to exploit such prior information in testing for G-E interaction. This can be
accomplished by adapting the methodology developed in the previous section upon noting
that the independence assumption implies α = 0, which, under the rare disease assumption,
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also implies that ω ≈ 0. This leads us to modify Ûi. Define U˜i similarly to Ûi with ω̂ = 0, i.e.
U˜i = (A1,i − p̂1(0)) (A2,i − p̂2(0))Di.
In the appendix, we show that σ2
U˜
= V ar(
∑
i U˜i/n) can be estimated by σ̂
2
U˜
= V̂1 + V̂2.
Consequently σ̂2
U˜
< σ̂2
Û
, reflecting the efficiency gain due to the independence assumption, i.e.
V̂3 is exactly zero since there is no uncertainty associated with ω̂ = 0. One can verify that the
non-centrality parameter β3 × κ1 of T1 =
∑
i U˜i/n
√
σ̂2
U˜
becomes κ1 =
σ
Û
σ
U˜
κ > κ, confirming
that T1 is guaranteed to be more powerful than T .
2.3 Adjusting for covariates
In observational studies, it is usually desirable to adjust for potential confounding of the
joint effects of A1 and A2, and such covariate adjustment may also be required to enforce
the G-E independence assumption. Let X denote such a vector of covariates and suppose
that the exposures are independent conditional on X. Define p1(x) = Pr(A1 = 1|X = x,D =
0) and p2(x) = Pr(A2 = 1|X = x,D = 0). Likewise, let p̂1(x) and p̂2(x) correspond to
estimates, obtained using standard parametric models, e.g. using logistic regressions of the
form logitp̂j(x) =logitpj(x; θ̂j) = (1, x
′)θ̂j, j = 1, 2, computed by maximum likelihood. The
test statistic T2 =
∑
i U i/
√
σ̂2
U
has under the null hypothesis of no additive interaction, an
approximate standard normal distribution, with U i defined as
U i = (A1,i − p̂1(X)) (A2,i − p̂2(X))Di,
where σ̂2
U
is obtained using equation (1) of the Appendix.
3 More general exposures
Next, suppose that the environmental exposure A2 were continuous, for example if D were di-
abetes status, A2 could be body mass index (BMI) typically coded on a continuous scale. Note
that the null hypothesis of no additive interaction can be restated as followed to acknowledge
the continuous exposure:
H0 : µ(1, a2, x)− µ(1, 0, x)− µ(0, a2, x) + µ(0, 0, x) = 0 for all values of a2 and x,
where µ(a1, a2, x) = Pr(D = 1|a1, a2, x). To construct an appropriate test statistic of H0,
suppose that E (A2|X = x,D = 0) is estimated with the linear model m̂2(x) = m2(x, θ̂2) =
(1, x′)θ̂2 via ordinary least squares using controls only. Assuming G-E conditional indepen-
7
dence given X, it is straightforward to modify the proposed test statistic to account for the
continuous exposure, by simply replacing p̂2(x) with m̂2(x). Thus, we let
U
c
i = (A1,i − p̂1(Xi)) (A2,i − m̂2(Xi))Di,
and σ̂2
U
c denotes an estimate of the variance of
∑
i U
c
i/n obtained using equation (1) of the
Appendix. Then, the test statistic T3 =
∑
i U
c
i/n
√
σ̂2
U
c is approximately standard normal
under H0.
A similar test statistic could be defined if A2 were a count, upon estimating its mean
with the log-linear model log n2(x, θ̂2) = (1, x
′)θ̂2 computed by maximum likelihood under
say a Poisson model for A2. Then, one could simply replace m̂2 with n̂2 in defining the test
statistic, and one could likewise modify the estimated variance of the test statistic using (1)
of the Appendix.
In order to simplify the presentation, thus far we have taken A1 to be a binary genetic
variant. Suppose now that A1 were more generally categorical having K possible levels
{0, a1,1, ..., a1,K−1} with 0 a reference value. For instance, if A1 were to encode the number of
minor alleles measured at a single nucleotide polymorphism (SNP) locus, then K = 3, and
a1,k = k, k = 1, 2. Further assuming say that A2 were continuous and independent of A1 given
X, we could then simply define
U
m
i =
K−1∑
k=1
(I(A1,i = a1,k)− p̂1,k(Xi)) (A2,i − m̂2(Xi))Di,
where p̂1,k(x) is a maximum likelihood estimate of Pr(A1 = ak|x) computed using standard
polytomous logistic regression. Let σ̂2
U
m denote an estimate of the large sample variance of∑
i U
m
i /n based on (1) of the Appendix. Then in large samples, the resulting test statistic
T4 =
∑
i U
m
i /n
√
σ̂2
U
m is approximate standard normal under the null hypothesis of no additive
interaction which may be restated to account for the polytomous and continuous exposures:
H0 : µ(a1,k, a2, x)−µ(a1,k, 0, x)−µ(0, a2, x)+µ(0, 0, x) = 0 for all k, and all values of a2 and x.
3.1 Failure of RERI-based approaches with continuous exposure
We now describe in some detail, the aforementioned failure of RERI-based approaches that use
standard logistic regression when at least one exposure is non-discrete and auxiliary covariates
are present. In this vein, suppose that A1 is continuous, while A2 may be binary. In practice,
to evaluate RERI in this context, one typically proceeds by estimating a standard logistic
regression for Pr {D = 1|a1, a2, x} using a simple parametric formulation of the model, such
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as:
logit Pr {D = 1|a1, a2, x;α0, α1, α2, α3, α4} = α0 + α1a2 + α2a1 + α3a1a2 + α′4x, (1)
where logit(p) =log{p/(1− p)} and the parameters (α0, α1, α2, α3, α4) are variation indepen-
dent [14]. Below, we argue that such a standard logistic regression will generally be incom-
patible with the null hypothesis of no additive interaction if both exposures (a1, a2) have a
non-null association with the outcome. Specifically, suppose that the main effects of A1 and
A2 and X are correctly specified in the logistic model, i.e.
logit Pr {D = 1|a1 = 0, a2, x} = α0 + α1a2 + α′4x
logit Pr {D = 1|a1, a2 = 0, x} = α0 + α2a1 + α′4x
with α1 6= 0 and α2 6= 0. Then there will generally be no parameter value of (α0, α1, α2, α3, α4)
that encodes the null hypothesis of no additive interaction, consequently any RERI-type test,
based on model (1) will generally have inflated type 1 error rate for testing the null of no
additive interaction. To further understand the failure of RERI in this context, note that
under the null hypothesis of no additive interaction
Pr{D=1|a1, a2, x}=Pr{D=1|a1 =0, a2, x}+Pr{D=1|a1, a2 =0, x}−Pr{D=1|a1 =0, a2 =0, x}
for all possible values of a1 and a2. Then under the null, the interaction function on the log
odds ratio scale is given by
θ (a1, a2, x;α0, α1, α2, α4)
= logit Pr {D = 1|a1, a2, x;α0, α1, α2, α4} − logit Pr {D = 1|a1 = 0, a2, x;α0, α1, α4}
− logit Pr {D = 1|a1, a2 = 0, x;α0, α2, α4}+ logit Pr {D = 1|a1 = 0, a2 = 0, x;α0, α4}
= logit{Pr {D = 1|a1 = 0, a2, x;α0, α1, α4}+ Pr {D = 1|a1, a2 = 0, x;α0, α2, α4}
− Pr {D = 1|a1 = 0, a2 = 0, x;α0, α4}}
− logit Pr {D = 1|a1 = 0, a2, x;α0, α1, α4} − logit Pr {D = 1|a1, a2 = 0, x;α0, α2, α4}
+ logit Pr {D = 1|a1 = 0, a2 = 0, x;α0, α4} ,
in which case, correct specification of a logistic model for Pr {D = 1|a1, a2, x} under a null
additive interaction is of the form
logit Pr {D = 1|a1, a2, x;α0, α1, α2, α4} = α0 + α1a2 + α2a1 + θ (a1, a2, x;α0, α1, α2, α4) + α′4x.
(2)
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Because of the nonlinear dependence of θ on a1 and x, it is clear that model (2) cannot be
nested in the standard logistic model (1), and therefore the latter cannot be used to obtain a
valid test of the null hypothesis of no additive interaction.
In order to implement an LRT of additive interaction using the RERI approach, an analyst
would need to carefully specify a model for the odds ratio interaction, so that model (2) is
recovered under the null of no additive interaction. Such a parametrization of the outcome
regression will characteristically be nonstandard in the sense that the interaction of the re-
sulting logistic model would need to be explicitly defined as a function of models for both
exposure main effects, and the effect of covariates. Such a parametrization of a logistic model
would seldom naturally arise in practice purely on scientific basis. Furthermore, one would
generally be unable to easily obtain parameter estimates for such a model using off-the-shelf
statistical software for standard logistic regression, which completely undermines the often
quoted practical advantage of the RERI approach.
4 A unified class of test statistics
We now provide a unified class of test statistics for the null hypothesis of no additive inter-
action which subsumes as special case, each of the settings considered in previous sections,
but which also allows for the conditional independence assumption of the two exposures to
be relaxed.
To do so, we proceed as in [15] and use the following representation of the joint density
of (A1, A2) given X :
f(A1, A2|X) = f(A1|A2 = 0, X)f(A2|A1 = 0, X)OR(A1, A2;X)∫ ∫
f(a1|A2 = 0, X)f(a2|A1 = 0, X)OR(a1, a2;X)dν(a1, a2) , (3)
where ν is a dominating measure of the distribution of (A1, A2) , OR(A1, A2;X) is the gener-
alized odds ratio function relating A1 and A2 within levels of X, that is
OR(A1, A2;X) =
f(A1, A2|X)f(A1 = 0, A2 = 0|X)
f(A1 = 0, A2|X)f(A1, A2 = 0|X)
and {f(A1|A2 = 0, X), f(A2|A1 = 0, X)} are baseline densities in the target population. Note
that the generalized odds ratio function reduces in the simple case of binary exposures, to
the standard odds ratio effect measure, but remains well defined as a measure of association
for exposures of a more general nature, whether categorical, count or continuous variables,
i.e. OR(A1, A2;X) = 1 if and only if A1 and A2 are independent within levels of X. The null
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hypothesis of no additive interaction can more generally be stated as:
H0 : µ(a1, a2, x)− µ(a1, 0, x)− µ(0, a2, x) + µ(0, 0, x) = 0 for all values of a1, a2 and x.
For any function g(A1, A2, X) of (A1, A2, X), let
w(A1, A2, X,D; g) = W (g)
= OR(A1, A2;X)
−1{g(A1, A2, X)−
∫
g(A1, a2, X)f(a2|A1 = 0, X)dµ(a2)
−
∫
g (a1, A2, X) f (a1|A2 = 0, X) dµ(a1)
+
∫
g(a1, a2, X)f (a2|A1 = 0, X) f (a1|A2 = 0, X) dµ(a1, a2)}D.
Lemma 1. The null hypothesis H0 holds if and only if
E {W (g)|D = 1, x} = 0 for all values of x and all functions g.
Result 1 is easily recovered as a corollary of Lemma 1. According to Lemma 1, an em-
pirical version of W (g) with user-specified function g may be used to test H0. One must
estimate the unknown odds ratio function and baseline densities, in order to obtain an esti-
mate of the joint density of (A1, A2) given X. Under the rare disease assumption, estimation
of the joint density can proceed by standard maximum likelihood in the controls only, us-
ing the parametrization given in equation (3), upon positing parametric models for the odds
ratio function and baseline densities. To ground ideas, suppose one posits parametric mod-
els OR(A1, A2;X;ω), f(A1|A2 = 0, X;α1) and f(A2|A1 = 0, X;α2), e.g. a single parameter
model logOR(A1, A2;X) = ωA1A2 may be used that encodes the assumption that the odds
ratio association between A1 and A2 given X does not vary with X, i.e. no effect het-
erogeneity in X of the odds ratio association between A1 and A2 in the population. For
exposures that are either binary, continuous or counts, generalized linear models within the
exponential family may be used to model the baseline densities. For example, counts may be
modeled by assuming a Poisson distribution for the corresponding baseline density. Let ω̂,
f̂(A1|A2 = 0, X) and f̂(A2|A1 = 0, X) denote the approximate maximum likelihood estimate
of (3) using controls only; and let Ŵ (g) = W (g, θ̂) denote the resulting estimate of W (g),
where θ = (ω, α1, α2). Our proposed test statistic is then given by Z =
∑
i Ŵi(g)/n
√
σ̂2W ,
where σ̂2W is the estimate of V ar
(∑
i Ŵi(g)/n
)
provided in the Appendix.
It is straightforward to verify that the test statistics considered in previous section belong
to the above unifying class of test statistics. For instance, the test statistics proposed to handle
11
binary, continuous or count exposures under the independence assumption are obtained by
taking:
g(A1, A2, X) = (A1 − E (A1|X)) (A2 − E (A2|X)) ,
where E (Aj|X) is the mean of Aj evaluated under f(Aj|X), j = 1, 2. For A1 categorical
with K distinct categories and A2 binary, continuous or a count, one likewise obtains the test
statistic previously proposed by taking:
g(A1, A2, X) =
K−1∑
k=1
(I(A1,i = a1,k)− E (I(A1,i = a1,k)|X)) (A2 − E (A2|X)) .
Under the independence assumption, the asymptotic variance of V ar
(∑
i Ŵi(g)/n
)
is easily
modified to account for the assumption that OR(A1, A2;X) is set to 1 for all persons in the
sample.
5 Relaxing the rare disease assumption
In case the rare disease assumption does not apply, estimating exposure regression models in
controls only may not be entirely appropriate. Nonetheless, it may still be possible to test
for the presence of an additive interaction, for instance if as often the case in nested case-
control studies, sampling fractions for cases and controls were known. Then, standard inverse
probability weighting could be used based on known sampling weights to estimate population
models for the exposures using both cases and controls. Potentially more efficient estimates
of models for the exposures could alternatively be obtained using more recent methodology
for regression analysis of secondary outcomes in case-control studies [16].
6 A simulation study
We study the power and type 1 error of our proposed test in the standard setting of binary
genetic and environmental variables with no other covariate, so that it is more easily compared
to the approach of [12]. In order to evaluate both type 1 error rates and power of various
test statistics, we generated simulated data following the design of [12] which encodes the
magnitude of the interaction indirectly by varying RERI from 0 (to assess type 1 error) to
0.5. The probability of having the genetic variant was 0.5, and the probability of the binary
environmental variable was 0.2, and these factors were generated to be independent. Let
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expit(z) = exp(z)/[exp(z) + 1] and logit(p) = log[p/(1− p)]. The disease risk model was
logit Pr(D = 1|a1, a2) = α0 + α1a1 + α2a2 + α3a1a2;
with baseline risk equal to 0.01 (i.e. α0 = logit(0.01)), the gene and environment main
effects were varied so that (α1, α2) ∈ {log(0.7), log(1.2), log(2)}, and the multiplicative G-E
interaction parameter α3 was selected to yield the desired RERI, according to the formula
α3 = logit[(RERI− 1)expit(α0) + expit(α0 + α1) + expit(α0 + α2)]− α0 − α1 − α2.
In each simulation, we generate 4000 cases and 4000 controls. We report results for 10,000
simulations for each setting corresponding to a particular combination of (α1, α2) and RERI
values.
Figure 1 summarizes results in terms of power comparing the proposed tests with and
without using the G-E independence assumption, labeled ‘U ind’ and ‘U’ respectively. The
figure also presents results for the retrospective profile likelihood ratio test proposed by [12]
with and without using the independence assumption respectively, labeled ‘Han ind’ and
‘Han’ respectively. Finally, the figure also displays results from the standard RERI test based
on prospective logistic regression, which is labeled ‘prosp’. Table 1 summarizes the type I
error rate of the various methods under ranging parameter values.
One observes that the RERI-LRT test ‘Han ind’ and ‘U ind’ are equally powerful when
Pr(G = 1) = 0.5 across various possible values for the other parameters, and both tests
are dramatically more powerful when compared to the other tests, while ‘U’ is slightly less
powerful than ‘Han’, which is in turn slightly less powerful than ‘prosp’.
In additional simulations, we varied the prevalence of the genetic marker Pr(G = 1) to
have population probabilities 0.2 and 0.05, while the environmental factor was maintained to
have probability 0.2. All tests appear to have correct type 1 error rate as shown in Table 1.
Power plots similar to those appearing in Figure 1 are provided in the supplementary material
for these additional settings. These additional simulations confirm that all tests become less
powerful as the genetic variant becomes less common, with ‘Han ind’ being slightly more
powerful than ‘U ind’ when Pr(G = 1) = 0.05. Overall, the simulation study confirms that
the proposed approach performs quite competitively when compared with the efficient RERI-
LRT approach, in settings where both methods are available.
In the following section, we consider a data application of the new approach in which
RERI is no longer readily available and cannot easily be applied without further making
unnecessary assumptions.
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Figure 1: Power of the various tests for identifying additive G-E interaction, in the simple
settings in which both a1 and a2 are binary, and no covariates are used in the model. The
simulated a1 is common Pr(a1 = 1) = 0.5, Pr(a2 = 1) = 0.2, and the disease model Pr(D =
1|a1, a2) has the fixed baseline risk α0 = logit(0.01), the main effects of the a1, a2 are varied as
α1, α2, and the RERI is varied from 0 to 0.5. The compared estimators are the proposed ‘U’
and ‘U ind’ (without and with assuming G-E independence), ‘prosp’ is the standard test under
prospective logistic regression and ‘Han’ and ‘Han ind’ is the retrospective profile likelihood
test proposed in [12] without and with assuming G-E independence.
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α1 : log(0.7) log(1.2) log(2)
α2 : log(0.7) log(1.2) log(2) α2 = log(0.7) log(1.2) log(2) log(0.7) log(1.2) log(2)
Pr(G = 1) = 0.5
U 0.048 0.049 0.051 0.050 0.048 0.049 0.049 0.050 0.048
U ind 0.047 0.048 0.049 0.047 0.047 0.049 0.046 0.046 0.048
prosp 0.050 0.048 0.047 0.048 0.048 0.046 0.046 0.049 0.049
Han 0.049 0.049 0.050 0.050 0.051 0.050 0.047 0.052 0.051
Han ind 0.047 0.048 0.050 0.047 0.048 0.049 0.046 0.046 0.048
Pr(G = 1) = 0.2
U 0.050 0.047 0.048 0.046 0.051 0.048 0.052 0.050 0.046
U ind 0.052 0.045 0.050 0.045 0.047 0.050 0.048 0.049 0.050
prosp 0.050 0.046 0.046 0.045 0.049 0.045 0.051 0.047 0.045
Han 0.051 0.048 0.050 0.048 0.050 0.048 0.055 0.051 0.050
Han ind 0.051 0.046 0.049 0.045 0.048 0.051 0.048 0.049 0.052
Pr(G = 1) = 0.05
U 0.050 0.054 0.053 0.054 0.054 0.050 0.051 0.049 0.048
U ind 0.052 0.057 0.050 0.051 0.051 0.050 0.048 0.047 0.048
prosp 0.043 0.048 0.050 0.042 0.047 0.045 0.042 0.043 0.041
Han 0.052 0.048 0.050 0.050 0.054 0.052 0.051 0.051 0.050
Han ind 0.052 0.052 0.049 0.050 0.049 0.046 0.047 0.048 0.048
Table 1: The type 1 error of the compared tests, under various combinations of the prevalence
of the genetic variant a1, and the effect of the genetic and environmental variables on the
disease outcome (α1 and α2, respectively). The tests ‘U’ and ‘U ind’ are the proposed tests
without and with the assumption of G-E independence. ‘prosp’ is the usual test based on
prospective likelihood, and ‘Han’ and ‘Han ind’ are the tests based on retrospective profile
likelihood proposed by [12]. The type 1 error was calculated from 10,000 simulations, each
with 4000 cases and 4000 controls.
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7 Ovarian cancer application
We applied the proposed test of additive interaction to the well-known Israeli Ovarian Can-
cer data [17] also recently analyzed by [9, 10, 11]. Although the goal in previous analyses
was to detect a multiplicative gene-environment interaction between having the BRCA1/2
mutation and two environmental exposures, number of years of oral contraceptive use (OC)
and number of children (parity), here we are primarily concerned with determining whether
such interactions might be operating on the additive scale. Both environmental exposures
are naturally coded as counts, and therefore can be modeled using Poisson regression, while
standard logistic regression was used to model the genetic variant. Both sets of models were
estimated only using controls as previously described. We present results when assuming
G-E independence, and without using such an assumption. Without G-E independence, the
odds ratio parameter ω was estimated as the coefficient for the exposure in view in a logistic
regression of the genetic factor on the environmental exposure and covariates, i.e. (E,X).
A number of covariates were available for confounding adjustment and also to enforce the
independence assumption. All regression models adjusted for age, as an indicator variable for
age≤ 50, indicator variables for ethnicities of Ashkenazi jew, and non-Ashkenazi (with mixed
race serving as reference category), indicator variables for personal history of breast cancer,
family history of breast cancer, and family history of ovarian cancer. For convenience, we
used the nonparametric bootstrap to evaluate 95% confidence intervals and p-values.
E variable U 95% CI p-values
G-E independence assumed
OC 0.049 (-0.006, 0.117) 0.09
Parity -0.044 (-0.092, -0.004) 0.03
No G-E independence assumed
OC 0.002 (-4.692, 0.012) 0.77
Parity -0.005 (-0.023, 0.019) 0.59
Table 2: Testing results for the additive G-E interaction between presence of BRCA1/2
mutation (G) and number of years of oral contraceptive (OC) use, and parity (E variables),
with and without G-E independence assumption. U is the proposed (standardized) test
statistic, and its 95% bootstrap confidence interval and p-value are provided, calculated over
1000 bootstrap samples.
The table provides results from testing for a G×E additive interaction with and without
making the G-E independence assumption. In accordance with simulation results, the inde-
pendence assumption yields a test statistic consistently more extreme for both exposures in
view than the corresponding test which does not incorporate the assumption. Specifically, we
successfully reject the null hypothesis of no additive G-E interaction between BRCA1/2 mu-
tation and parity at the alpha level= 0.05, only when the independence assumption is made,
16
and not otherwise. We found no conclusive evidence of an additive interaction with OC,
although the test statistic under G-E independence was far more extreme than without the
assumption and the associated p-value was marginally significant (p-value=0.09). It is inter-
esting to compare these findings with previous analyses of these data that have primarily been
concerned with detecting the presence of a multiplicative G×E interaction. For instance, [10]
leveraged the independence assumption to detect a G×E multiplicative interaction only with
OC and failed to find evidence of a similar interaction with parity, thus essentially reporting
the opposite findings to ours. However, our findings are potentially more scientifically relevant
given that interactions on the multiplicative scale may be harder to interpret biologically.
8 Conclusion
We have described a very general framework to test for G×E additive interactions exploit-
ing G-E independence in case-control studies. The proposed strategy has several advantages
over existing RERI-based strategies, primarily because, unlike the latter, the former does not
require a regression model for the outcome, and therefore is less vulnerable to model misspeci-
fication of the outcome regression, a potential concern particularly if E is a count or continuous
and additional covariates are included in the regression. The approach put forward in this
paper is closely related to the semiparametric framework of [18], who characterized the set of
influence functions of a model of interaction (on the additive or multiplicative scale) under a
semiparametric union model in which only a subset but not all of the parametric models used
to describe the data generating mechanism need to be correct for valid inference. In fact,
one can show that our proposed test statistic belongs to the general class of test statistics for
additive interaction associated with their set of influence functions. However, because [18] did
not allow for outcome dependent sampling and only considered standard prospective random
sampling, not all test statistics in their class may be used under case-control sampling. Thus,
an important contribution of the current paper has been to characterize the subset of the
class of test statistics of an additive interaction that may be used both under prospective and
retrospective sampling.
An important limitation of the proposed approach is that it does not readily produce an
estimate of the risk difference parameters which are often of primary interest for understanding
the public health significance of any significant finding. To obtain such estimates, one would
need an estimate of the main effect of exposures, which are being treated as unspecified
nuisance parameters in the proposed approach from the ground of robustness. Addressing
this limitation is a priority for future research to extend the methods describe herein.
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Appendix
Proof that V ar(
∑
i Ûi/n) > V ar(
∑
i U˜i/n).
To show the result requires the influence function of θ̂ = (ω̂, p̂1 = p̂1(0), p̂2 = p̂2(0))
T which is
of the form
IF = E
(
∂R (θ)
∂θ
)−1
R (θ)
where R (θ) = {(1−D)(1− A2)× [(A1 − E (A1, θ)], (1−D)(1− A1)× [A2 − E (A2; θ)], (1−
D) × [A1A2 − E (A1A2; θ)]}T , where the first component is the score of p1(0), the second
component is the score of p2(0), the last component is the score of ω, and θ = (ω, p1, p2) .
Standard matrix algebra can be used to show that at the submodel where A1 and A2 are
independent IF = (IF1, IF2, IF3) where:
IF1 = E [(1− A2) (1−D)]−1 (1− A2) (A1 − E (A1)) (1−D)
≈ −E [(1− E (A2|D = 0))]−1 (A2 − E (A2|D = 0)) (A1 − E (A1|D = 0)) (1−D)
+ (A1 − E (A1|D = 0)) (1−D)
IF2 = E [(1− A1) (1−D)]−1 (1− A1) (A2 − E (A2)) (1−D)
≈ −E [(1− E (A1|D = 0))]−1 (A1 − E (A1|D = 0)) (A2 − E (A2|D = 0)) (1−D)
+ (A2 − E (A2|D = 0)) (1−D)
IF3 = E
[
(A1 − E (A1|D = 0))2 |D = 0
]−1 E [(A2 − E (A2|D = 0))2 |D = 0]−1
× (A1 − E (A1|D = 0)) (A2 − E (A2|D = 0)) (1−D)
A Taylor series argument then gives∑
i
Ûi/
√
n
≈
∑
i
Ui/
√
n− E [(A2 − p2(0))D] IF1
− E [(A1 − p1(0))D] IF2 − E [A1A2 (A2 − p2(0)) (A1 − p1(0))D] IF3
=
∑
i
Ui/
√
n
− E [(A2 − p2(0))D]
∑
i
(A1,i − E (A1|D = 0)) (1−Di)/
√
n
− E [(A1 − p1(0))D]
∑
i
(A2,i − E (A2|D = 0)) (1−Di)/
√
n
−
(
E [A1A2 (A2 − p2) (A1 − p1)D] {p1p2 (1− p1) (1− p2)}−1
+E [(A2 − p2)D] [(1− p2)]−1 + E [(A1 − p1)D] [(1− p1)]−1
)
×
∑
i
(A1,i − E (A1|D = 0)) (A2,i − E (A2|D = 0)) (1−Di)/
√
n
Upon noting that the above four terms are mutually uncorrelated, we have that :
V ar
(∑
i
Ûi/n
)
≈ V1 + V2 + V3
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where
V1 = V ar (U) /n
V2 = E [(A2 − p2(0))D]2 V ar ((A1 − E (A1|D = 0)) (1−D)) /n
+ E [(A1 − p1(0))D]2 V ar ((A2 − E (A2|D = 0)) (1−D)) /n
V3 =
(
E [A1A2 (A2 − p2) (A1 − p1)D] {p1p2 (1− p1) (1− p2)}−1
+E [(A2 − p2)D] [(1− p2)]−1 + E [(A1 − p1)D] [(1− p1)]−1
)2
× V ar ((A1 − E (A1|D = 0)) (A2 − E (A2|D = 0)) (1−D)) /n
A similar derivation shows that∑
i
U˜i/
√
n
≈
∑
i
Ui/
√
n
− E [(A2 − p2(0))D]
∑
i
(A1,i − E (A1|D = 0)) (1−Di)/
√
n
− E [(A1 − p1(0))D]
∑
i
(A2,i − E (A2|D = 0)) (1−Di)/
√
n
which gives
V ar
(∑
i
U˜i/n
)
≈ V1 + V2
proving the result.
Asymptotic variance for unified class of test statistics Our proposed test statistic
is then given by Z =
∑
i Ŵi(g)/nσ̂W , where σ̂
2
W is an estimate of V ar
(∑
i Ŵi(g)/n
)
one can
derive using a standard Taylor series argument:
V ar
(∑
i
Ŵi(g)/n
)
≈ n−1V ar (W (g, θ)) + n−1E (W Tθ (g))V ar (S†θ)E (Wθ(g)) (4)
where Wθ(g) is the derivative of W (g, θ) with respect to θ evaluated at the truth, and S
†
θ
is the influence function of θ̂ [15]. For instance, when θ̂ is a maximum likelihood estimator,
S†θ = E
(
SθS
T
θ
)−1
Sθ, where Sθ denote the score of θ. Under the assumption that A1 and
A2 are independent, we may set ω̂ = 1 and redefine θ = (α1, α2) ,also note that under
independence, the joint density (3) simplifies to f(A1, A2|X) = f(A1|X)f(A2|X), leading to
some simplification in the above expression for the asymptotic variance of the test statistic.
Proof of Lemma 1. Consider the nonparametric additive representation of µ(a1, a2, x)
given by µ(a1, a2, x) = β1(a1, x) + β2(a2, x) + β3(a1, a2, x) + β4(x) where β1(a1, x) is the main
effect of A1 and satisfies β1(0, x) = 0, likewise β2(a2, x) is the main effect of A2 and sat-
isfies β2(0, x) = 0, β3(a1, a2, x) is the additive interaction between A1 and A2 and satisfies
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β3(0, a2, x) = β3(a1, 0, x) = 0, and β4(x) is the main effect of X. For any function g, note
that
E {W (g)|D = 1, x}
=
∫ ∫
w(a1, a2, x, 1; g)µ(a1, a2, x)f(a1, a2|x)f(x)dν(a1, a2)/
∫ ∫
µ(a1, a2, x)f(a1, a2|x)f(x)dν(a1, a2)
∝
∫ ∫
w(a1, a2, x, 1; g)µ(a1, a2, x)f(a1|A2 = 0, x)f(a2|A1 = 0, x)OR(a1, a2;x)dν(a1, a2)
=
∫ ∫
w(a1, a2, x, 1; g)β3(a1, a2, x)f(a1|A2 = 0, x)f(a2|A1 = 0, x)OR(a1, a2;x)dν(a1, a2)
since ∫
w (a1, a2, x, 1; g) β1 (a1, x) f (a2|A1 = 0, x)OR (a1, a2;x) dν (a2)
= {β1(a1, x)
∫
g(A1, A2, X)f(a2|A1 = 0, x)dν(a2)
− β1 (a1, x)
∫
g (A1, a2, X) f (a2|A1 = 0, X) dµ(a2)
− β1(a1, x)
∫ ∫
g (a1, A2, X) f (a1|A2 = 0, X) dµ(a1)f (a2|A1 = 0, X) dν(a2)
+ β1(a1, x)
∫ ∫
g (a1, a2, X) f (a1|A2 = 0, X) f (a2|A1 = 0, X) dµ(a1)dµ(a2)
= 0
furthermore by symmetry,∫
w (a1, a2, x, 1; g) β2 (a2, x) f (a1|A2 = 0, x)OR (a1, a2;x) dν (a1)
= 0
and finally∫
w (a1, a2, x, 1; g) β4(x)f (a2|A1 = 0, x)OR (a1, a2;x) dν (a2)
= {β4(x)
∫
g(A1, A2, X)f(a2|A1 = 0, x)dν(a2)
− β4(x)
∫
g (A1, a2, X) f (a2|A1 = 0, X) dµ(a2)
− β4(x)
∫ ∫
g (a1, A2, X) f (a1|A2 = 0, X) dµ(a1)f (a2|A1 = 0, X) dν(a2)
+ β4(x)
∫ ∫
g (a1, A2, X) f (a1|A2 = 0, X) f (a2|A1 = 0, X) dµ(a1)dµ(a2)
= 0
therefore ∫ ∫
w(a1, a2, x, 1; g) {β1(a1, x) + β2(a2, x) + β4(x)}
× f (a1|A2 = 0, x) f (a2|A1 = 0, x) dν(a1, a2)
= 0
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for any choice of g. Thus, the null of no additive interaction β3(a1, a2, x) = 0 for all (a1, a2, x)
implies that E {W (g)|D = 1, x} = 0. We get the result in the other direction by choosing
g(a1, a2, x) = g
∗(a1, a2, x) = β3(a1, a2, x) which gives
E {W (g)|D = 1, x} = 0 for all g and x implies that∫ ∫
w(a1, a2, x, 1; g
∗)2f(a1|A2 = 0, x)f(a2|A1 = 0, x)dν(a1, a2) = 0 for all x
which in turn implies that β3(a1, a2, x) = 0 for all (a1, a2, x) proving the result. 
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Figure 2: Power of the various tests for identifying additive G-E interaction, in the simple
settings in which both a1 and a2 are binary, and no covariates are used in the model. The
simulated a1 is common Pr(a1 = 1) = 0.05, Pr(a2 = 1) = 0.2, and the disease model
Pr(D = 1|a1, a2) has the fixed baseline risk α0 = logit(0.01), the main effects of the a1, a2
are varied as α1, α2, and the RERI is varied from 0 to 0.5. The compared estimators are
the proposed ‘U’ and ‘U ind’ (without and with assuming G-E independence), ‘prosp’ is the
standard test under prospective logistic regression and ‘Han’ and ‘Han ind’ is the retrospective
profile likelihood test proposed in Han (2012) without and with assuming G-E independence.
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Figure 3: Power of the various tests for identifying additive G-E interaction, in the simple
settings in which both a1 and a2 are binary, and no covariates are used in the model. The
simulated a1 is common Pr(a1 = 1) = 0.2, Pr(a2 = 1) = 0.2, and the disease model Pr(D =
1|a1, a2) has the fixed baseline risk α0 = logit(0.01), the main effects of the a1, a2 are varied as
α1, α2, and the RERI is varied from 0 to 0.5. The compared estimators are the proposed ‘U’
and ‘U ind’ (without and with assuming G-E independence), ‘prosp’ is the standard test under
prospective logistic regression and ‘Han’ and ‘Han ind’ is the retrospective profile likelihood
test proposed in Han (2012) without and with assuming G-E independence.
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